Le Lézard
Classified in: Health, Covid-19 virus
Subject: POL

AACC Urges Congress to Fund Laboratory Training Programs to Better Prepare the U.S. for Future Pandemics


WASHINGTON, Sept. 17, 2020 /PRNewswire/ -- In the face of a chronic shortage of professionals who are qualified to perform clinical laboratory tests?including those for COVID-19?AACC released a position statement today calling on Congress to provide federal funding to expand clinical laboratory training programs. This will help to ensure that labs have the staffing they need to deliver timely, accurate test results, particularly during public health emergencies such as the current coronavirus pandemic.

Read the position statement here: https://www.aacc.org/health-and-science-policy/advocacy/position-statements/2020/modernization-of-clia-moderate-and-high-complexity-testing

In spite of labs' heroic efforts to meet the demand for coronavirus testing in the U.S., the country's overall testing capacity continues to fall short of the levels needed to help contain the pandemic. As part of an ongoing AACC survey of U.S. labs, the association has found that a lack of staff is one of the major challenges hindering these critical testing efforts, with 58% of labs reporting this issue. This finding isn't a surprise, as the nation's laboratory workforce has been shrinking for decades. For example, in 1990, there were 720 training programs for medical laboratory scientists across the U.S., but that number has now dropped by 15% to only 608. As a result, these training programs no longer produce enough graduates to fill existing lab vacancies. Over the next 10 years, clinical laboratories will need approximately 7,000 new medical laboratory scientists annually, but laboratory training programs currently only graduate 6,000 students a year, leaving a sizeable deficit.

To reverse this trend and ensure that labs have sufficient qualified staff, AACC urges Congress to restore federal funding for medical laboratory scientist training programs. This would give these programs the resources they need to train more students. Lawmakers should also allocate funding to hospitals and/or reference laboratories that provide clinical testing rotations to students from medical laboratory scientist programs. This would help to alleviate another issue that has contributed to the lab staffing shortage, which is the dwindling number of hospital laboratories that are willing to provide students with the supervised clinical experiences that are essential for a complete medical laboratory scientist education. Lastly, AACC recommends that legislators create a loan forgiveness program for clinical laboratory professionals willing to work in underserved areas for a specified period, which could incentivize individuals to enter the field.

"The coronavirus pandemic has shone a spotlight on how crucial high quality testing is to patient care and public health," said AACC President Dr. David G. Grenache. "But the current crisis has also revealed the weak points in our country's testing infrastructure, such as the fact that the U.S. has allowed the number of laboratory training programs to diminish for years now. We at AACC strongly encourage Congress to restore funding for these programs so that labs can build up the capacity they need to continue to support the country's response to public health crises such as COVID-19."

About AACC
Dedicated to achieving better health through laboratory medicine, AACC brings together more than 50,000 clinical laboratory professionals, physicians, research scientists, and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of progressing laboratory science. Since 1948, AACC has worked to advance the common interests of the field, providing programs that advance scientific collaboration, knowledge, expertise, and innovation. For more information, visit www.aacc.org.

Christine DeLong
AACC
Senior Manager, Communications & PR
(p) 202.835.8722
[email protected]

Molly Polen
AACC
Senior Director, Communications & PR
(p) 202.420.7612
(c) 703.598.0472
[email protected] 

 

SOURCE AACC


These press releases may also interest you

at 12:50
Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming June 11, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired QuidelOrtho Corporation ("QuidelOrtho"...

at 11:40
The "Global Needle Coke Market: Focus on Application, Type, Grade, End Use, and Country-Level Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The global needle coke market was valued at $3.05...

at 11:15
Expomed Eurasia, the most important medical exhibition between Europe and Asia, is ready to house more than a hundred companies, to discover new technological trends and the most innovative products which are going to change deeply the health market....

at 11:15
Nora Pharma, a Canadian pharmaceutical company, has received approval for its first Biosimilar product. Nora Pharma, a wholly owned division of Sunshine Biopharma, has received approval from Health Canada for the commercialization of NIOPEG® (a...

at 09:35
Two large multi-state studies uncovered a highly effective way to improve antibiotic selection for patients hospitalized with pneumonia or urinary tract infections (UTI), enabling better antibiotic stewardship in hospitals, according to research...

at 09:25
The "The U.S. Telehealth Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering The report includes in-depth analyses of: the scope of telehealth usage in the U.S., telehealth user demographics, pros and...



News published on and distributed by: